The impact of private use of PCV7 in 2009 and 2010 on serotypes and antimicrobial resistance of Streptococcus pneumoniae carried by young children in Portugal: Comparison with data obtained since 1996 generating a 15-year study prior to PCV13 introduction

Vaccine

Volumn 34, Issue 14, 2016, Pages 1648-1656

  Nunes, Sónia ^a   Félix, Sofia ^a   Valente, Carina ^a   Simões, Alexandra S ^a   Tavares, Débora A ^a   Almeida, Sónia T ^a   Paulo, Ana C ^a   Brito Avô, António ^b   de Lencastre, Hermínia ^a,c   Sá Leão, Raquel ^a  

^a INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

^b Private Clinic   (Portugal)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Antimicrobial resistance; Carriage; Children; Pneumococcal conjugate vaccine; Serotype; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN; BETA LACTAM; CEFTRIAXONE; CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; MACROLIDE; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE; TETRACYCLINE; VACCINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CHILD; COHORT ANALYSIS; COMPARATIVE STUDY; CORRELATION ANALYSIS; DAY CARE; DRUG EFFECT; DRUG USE; HUMAN; INFANT; MAJOR CLINICAL STUDY; NASOPHARYNX; NEWBORN; PORTUGAL; PRESCHOOL CHILD; PRIORITY JOURNAL; QUESTIONNAIRE; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; URBAN AREA; CLASSIFICATION; EPIDEMIOLOGY; FEMALE; HETEROZYGOTE; ISOLATION AND PURIFICATION; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PNEUMOCOCCAL INFECTIONS; STATISTICS AND NUMERICAL DATA; VACCINATION;

BACTERIAL TYPING TECHNIQUES; CARRIER STATE; CHILD; CHILD DAY CARE CENTERS; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; FEMALE; HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; NASOPHARYNX; PNEUMOCOCCAL INFECTIONS; PORTUGAL; SEROGROUP; STREPTOCOCCUS PNEUMONIAE; VACCINATION; VACCINES, CONJUGATE;

EID: 84960384698     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2016.02.045     Document Type: Article

References (35)

1. Bogaert D., De Groot R., Hermans P.W. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis 2004, 4(Mar (3)):144-154.
2. Sá-Leão R., Nunes S., Brito-Avô A., Alves C.R., Carriço J.A., Saldanha J., et al. High rates of transmission of and colonization by Streptococcus pneumoniae and Haemophilus influenzae within a day care center revealed in a longitudinal study. J Clin Microbiol 2008, 46(Jan (1)):225-234.
3. Hausdorff W.P., Bryant J., Paradiso P.R., Siber G.R. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis 2000, 30(Jan (1)):100-121.
4. De Carvalho Gomes H., Muscat M., Monnet D.L., Giesecke J., Lopalco P.L. Use of seven-valent pneumococcal conjugate vaccine (PCV7) in Europe, 2001-2007. Euro Surveill 2009, 14(Mar (12)).
5. Pilishvili T., Lexau C., Farley M.M., Hadler J., Harrison L.H., Bennett N.M., et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 2010, 201(Jan (1)):32-41.
6. Huang S.S., Hinrichsen V.L., Stevenson A.E., Rifas-Shiman S.L., Kleinman K., Pelton S.I., et al. Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics 2009, 124(Jul (1)):e1-e11.
7. Whitney C.G., Pilishvili T., Farley M.M., Schaffner W., Craig A.S., Lynfield R., et al. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet 2006, 368(Oct (9546)):1495-1502.
8. Comissão de Vacinas da Sociedade de Infeciologia Pediátrica (SIP) e Sociedade ortuguesa de Pediatria (SPP). Recomendações para a vacinação anti-pneumocócica 2009.
9. Nunes S., Sá-Leão R., Carriço J., Alves C.R., Mato R., Avô A.B., et al. Trends in drug resistance, serotypes, and molecular types of Streptococcus pneumoniae colonizing preschool-age children attending day care centers in Lisbon, Portugal: a summary of 4 years of annual surveillance. J Clin Microbiol 2005, 43(Mar (3)):1285-1293.
10. Mato R., Sanches I.S., Simas C., Nunes S., Carriço J.A., Sousa N.G., et al. Natural history of drug-resistant clones of Streptococcus pneumoniae colonizing healthy children in Portugal. Microb Drug Resist 2005, 11(Winter (4)):309-322.
11. Simões A.S., Pereira L., Nunes S., Brito-Avô A., de Lencastre H., Sá-Leão R. Clonal evolution leading to maintenance of antibiotic resistance rates among colonizing Pneumococci in the PCV7 era in Portugal. J Clin Microbiol 2011, 49(Aug (8)):2810-2817.
12. Sá-Leão R., Nunes S., Brito-Avô A., Frazão N., Simões A.S., Crisóstomo M.I., et al. Changes in pneumococcal serotypes and antibiotypes carried by vaccinated and unvaccinated day-care centre attendees in Portugal, a country with widespread use of the seven-valent pneumococcal conjugate vaccine. Clin Microbiol Infect 2009, 15(Nov (11)):1002-1007.
13. Almeida S.T., de Lencastre H., Sá-Leão R. Epidemiology and population structure of serotypes 1, 5 and 7F carried by children in Portugal from 1996-2010 before introduction of the 10-valent and 13-valent pneumococcal conjugate vaccines. PLOS ONE 2013, 8(9):e75442.
14. Nunes S., Valente C., Sá-Leão R., de Lencastre H. Temporal trends and molecular epidemiology of recently described serotype 6C of Streptococcus pneumoniae. J Clin Microbiol 2009, 47(Feb (2)):472-474.
15. Aguiar S.I., Pinto F.R., Nunes S., Serrano I., Melo-Cristino J., Sá-Leão R., et al. Denmark14-230 clone as an increasing cause of pneumococcal infection in Portugal within a background of diverse serotype 19A lineages. J Clin Microbiol 2010, 48(Jan (1)):101-108.
16. Satzke C., Turner P., Virolainen-Julkunen A., Adrian P.V., Antonio M., Hare K.M., et al. Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: update recommendations from the World Health Organization Pneumococcal Carriage Woing Grp. Vaccine 2014, 32:165-179.
17. Pai R., Gertz R.E., Beall B. Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J Clin Microbiol 2006, 44(Jan (1)):124-131.
18. Sorensen U.B. Typing of pneumococci by using 12 pooled antisera. J Clin Microbiol 1993, 31(Aug (8)):2097-2100.
19. Simões A.S., Valente C., de Lencastre H., Sá-Leão R. Rapid identification of noncapsulated Streptococcus pneumoniae in nasopharyngeal samples allowing detection of co-colonization and reevaluation of prevalence. Diagn Microbiol Infect Dis 2011, 71(Nov (3)):208-216.
20. CLSI Performance standards for antimicrobial susceptibility testing: aproved standard-tenth edition M02-A10 2009, Clinical and Laboratory Standards Institute, Wayne, PA, USA.
21. R Core Team A language and environment for statistical computing 2014, R Foundation for Statistical Computing, Vienna, Austria.
22. Huang S.S., Platt R., Rifas-Shiman S.L., Pelton S.I., Goldmann D., Finkelstein J.A. Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics 2005, 116(Sep (3)):e408-e413.
23. Keck J.W., Wenger J.D., Bruden D.L., Rudolph K.M., Hurlburt D.A., Hennessy T.W., et al. PCV7-induced changes in pneumococcal carriage and invasive disease burden in Alaskan children. Vaccine 2014, 32(Nov (48)):6478-6484.
24. Flasche S., Van Hoek A.J., Sheasby E., Waight P., Andrews N., Sheppard C., et al. Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study. PLoS Med 2011, 8(Apr (4)):e1001017.
25. Cohen R., Levy C., Bonnet E., Grondin S., Desvignes V., Lecuyer A., et al. Dynamic of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 introduction in France. Vaccine 2010, 28(Aug (37)):6114-6121.
26. Cho E.Y., Kang H.M., Lee J., Kang J.H., Choi E.H., Lee H.J. Changes in serotype distribution and antibiotic resistance of nasopharyngeal isolates of Streptococcus pneumoniae from children in Korea, after optional use of the 7-valent conjugate vaccine. J Korean Med Sci 2012, 27(Jul (7)):716-722.
27. Rodrigues F., Nunes S., Sá-Leão R., Gonçalves G., Lemos L., de Lencastre H. Streptococcus pneumoniae nasopharyngeal carriage in children attending day-care centers in the central region of Portugal, in the era of 7-valent pneumococcal conjugate vaccine. Microb Drug Resist 2009, 15(Dec (4)):269-277.
28. Kaplan S.L., Barson W.J., Lin P.L., Stovall S.H., Bradley J.S., Tan T.Q., et al. Serotype 19A Is the most common serotype causing invasive pneumococcal infections in children. Pediatrics 2010, 125(Mar (3)):429-436.
29. Aguiar S.I., Brito M.J., Gonçalo-Marques J., Melo-Cristino J., Ramirez M. Serotypes 1, 7F and 19A became the leading causes of pediatric invasive pneumococcal infections in Portugal after 7 years of heptavalent conjugate vaccine use. Vaccine 2010, 28(Jul (32)):5167-5173.
30. Aguiar S.I., Brito M.J., Horácio A.N., Lopes J.P., Ramirez M., Melo-Cristino J. Decreasing incidence and changes in serotype distribution of invasive pneumococcal disease in persons aged under 18 years since introduction of 10-valent and 13-valent conjugate vaccines in Portugal, July 2008 to June 2012. Euro Surveill 2014, 19(12):20750.
31. Cohen R., Levy C., Bingen E., Koskas M., Nave I., Varon E. Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media. Pediatr Infect Dis J 2012, 31(Mar (3)):297-301.
32. Kaplan S.L., Barson W.J., Lin P.L., Romero J.R., Bradley J.S., Tan T.Q., et al. Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 2013, 32(Mar (3)):203-207.
33. Lipsitch M. Vaccination against colonizing bacteria with multiple serotypes. Proc Natl Acad Sci USA 1997, 94(Jun (12)):6571-6576.
34. Rudolph K., Bruce M., Bruden D., Zulz T., Wenger J., Reasonover A., et al. Epidemiology of pneumococcal serotype 6A and 6C among invasive and carriage isolates from Alaska, 1986-2009. Diagn Microbiol Infect Dis 2013, 75(Mar (3)):271-276.
35. Adriaenssens N., Coenen S., Versporten A., Muller A., Vankerckhoven V., Goossens H. European Surveillance of Antimicrobial Consumption (ESAC): quality appraisal of antibiotic use in Europe. J Antimicrob Chemother 2011, 66(Dec (Suppl. 6)):vi71-vi77.